Idenix appoints Daniella Beckman CFO
This article was originally published in Scrip
Idenix Pharmaceuticals has appointed Daniella Beckman vice president, chief financial officer and treasurer. Ms Beckman served as the company's interim CFO and treasurer from October 2010 to June 2011, and was previously corporate controller for Idenix and before that Coley Pharmaceutical Group.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.